Manhattan Scientifics Inc (MHTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 90 | 175 | 288 | 386 | 121 |
| Other current assets | 0 | 0 | 0 | 0 | 300 |
| TOTAL | $115 | $189 | $296 | $400 | $440 |
| Non-Current Assets | |||||
| PPE Net | 1 | 1 | 2 | 2 | 3 |
| Investments And Advances | 576 | 839 | 1,064 | 960 | 2,444 |
| Other Non-Current Assets | 2 | 2 | 2 | 2 | 2 |
| TOTAL | $579 | $842 | $1,068 | $964 | $2,449 |
| Total Assets | $694 | $1,031 | $1,364 | $1,364 | $2,889 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 134 | 119 | 115 | 118 | 107 |
| Accrued Expenses | 1,537 | 1,439 | 1,351 | 1,273 | 1,201 |
| TOTAL | $1,751 | $1,668 | $1,605 | $1,534 | $1,443 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 10 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 1,058 | 1,058 | 1,058 | 1,058 | 1,058 |
| TOTAL | $1,058 | $1,058 | $1,058 | $1,058 | $1,058 |
| Total Liabilities | $2,809 | $2,726 | $2,663 | $2,592 | $2,501 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 559,281 | 559,281 | 559,281 | 559,281 | 559,281 |
| Common Shares | 559 | 559 | 559 | 559 | 559 |
| Retained earnings | -71,670 | -71,250 | -70,854 | -70,783 | -69,167 |
| TOTAL | $-2,115 | $-1,695 | $-1,299 | $-1,228 | $388 |
| Total Liabilities And Equity | $694 | $1,031 | $1,364 | $1,364 | $2,889 |